Scott C Lester
Overview
Explore the profile of Scott C Lester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar A, Jakub J, Lester S, Markovic S, Baum C
J Am Acad Dermatol
. 2025 Mar;
PMID: 40074149
In-transit metastases (ITM) are estimated to occur in 5-10% of primary cutaneous melanomas. They are classified as stage III disease in the American Joint Committee on Cancer classification system and...
2.
Guenzel R, Breen W, Go R, Feldman A, Lester S
Adv Radiat Oncol
. 2025 Feb;
10(3):101710.
PMID: 39897384
No abstract available.
3.
Kukla A, Lester S, Iqbal A, Razonable R, Issa N, Riad S, et al.
Am J Transplant
. 2025 Jan;
PMID: 39828231
Treating acute rejection of a pancreas transplant in a severely immunocompromised patient with viral opportunistic infection is challenging due to the balance of rescuing from rejection without worsening the morbidity...
4.
Owen D, Harmsen W, Ahmed S, Petersen I, Haddock M, Ma D, et al.
Pract Radiat Oncol
. 2024 Dec;
PMID: 39725127
Objectives: Spatially fractionated radiation therapy (SFRT) intentionally delivers a heterogeneous dose distribution characterized by alternating regions of high and low doses throughout a tumor. This modality may enhance response to...
5.
Gao R, Fleuranvil R, Harmsen W, Tao R, Pulsipher S, Greipp P, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Oct;
25(3):212-218.
PMID: 39477700
Introduction: We performed a retrospective analysis of patients with multiple myeloma (MM) receiving palliative radiotherapy (RT) and assessed factors associated with local control, with a focus on dose/fractionation and cytogenetics....
6.
Lester S, Johnson E, Breen W, Khurana A
Adv Radiat Oncol
. 2024 Sep;
9(9):101559.
PMID: 39253333
No abstract available.
7.
Armstrong M, Burkett B, OByrne T, Gottlich H, Yin L, Tasche K, et al.
JAMA Otolaryngol Head Neck Surg
. 2024 Aug;
150(12):1078-1086.
PMID: 39207815
Importance: Asymmetric oropharynx uptake on positron emission tomography (PET)/computed tomography (CT) is a common incidental finding and often prompts otolaryngology referral to rule out malignancy; however, the true risk of...
8.
Saifi O, Breen W, Lester S, Rule W, Stish B, Rosenthal A, et al.
Blood Adv
. 2024 Jul;
8(18):4877-4885.
PMID: 39028948
Unirradiated patients with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) who undergo anti-CD19 chimeric antigen receptor T-cell therapy (CART) have a predominant localized pattern of relapse, the significance of which is...
9.
Grams M, Mateus C, Mashayekhi M, Mutter R, Djonov V, Fazzari J, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jul;
120(5):1423-1434.
PMID: 39002850
Purpose: Minibeam radiation therapy (MBRT) is characterized by the delivery of submillimeter-wide regions of high "peak" and low "valley" doses throughout a tumor. Preclinical studies have long shown the promise...
10.
Holtzman A, Mohammadi H, Furutani K, Koffler D, McGee L, Lester S, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893068
Proton therapy has emerged as a crucial tool in the treatment of head and neck and skull-base cancers, offering advantages over photon therapy in terms of decreasing integral dose and...